1,1′-Diphosphaferrocene Derivatives
Organometallics, Vol. 17, No. 26, 1998 5881
be readily detected and quantified by various techniques
including atomic absorption spectroscopy (AAS),5 elec-
trochemical methods,6 and Fourier transform IR spec-
troscopy.7 In the latter case metal carbonyl labels are
used, detectable in the region of the stretching vibra-
tions of coordinated CO (2100-1850 cm-1), where bio-
molecules and biological matrixes are practically trans-
parent. An immunoassay technique using metal carbonyl
markers (carbonylmetalloimmunoassay, CMIA) was
recently introduced and successfully applied for simul-
taneous quantification of two or three haptenes.7c,d
Th e fer r ocen e m oiety has been coupled with redox
enzymes such as glucose and galactose oxidases to
enable electronic communication between the enzyme
and an electrode (“wiring” of enzymes)8 and with a
variety of medications to afford tracers for electroim-
munoassays.9 Ferrocenyl amino acids have also been
synthesized for incorporation into a polypeptide chain
to study the role of the peptidic backbone in electron-
transfer processes.10 Finally, ferrocene probes are widely
used in studies of molecular recognition processes.11
The last two decades have witnessed a remarkable
progress in synthetic methods and in the understanding
of the structure and reactivity of 1,1′-diheteroferrocenes
of the group 15 elements.12 Similarly to ferrocene, these
complexes display more or less reversible redox chem-
istry, but additionally they are able to bind one or two
metal centers through the heteroatom lone pairs.13 In
our opinion these features make them particularly
interesting as versatile labeling reagents for in vitro
assays, with potential applications in redox enzyme
assays or electroctrochemical immunoassays, carbonyl-
metalloimmunoassays (when a metal carbonyl fragment
is bound to the heterometallocene), and radioimmuno-
therapy (when a suitable radioactive metal fragment is
bound to the heterometallocene moiety linked, for
example, to an antibody). Obviously these anticipated
applications will require a detailed knowledge of biologi-
cal properties of 1,1′-diheteroferrocenes such as their
stability in biological media, ability to cross biological
membranes, or toxicity.
In this paper we describe the synthesis, starting from
the readily available 3,3′4,4′-tetramethyl-1,1′-diphos-
phaferrocene (1),14 of 4-oxo-4-(3,3′,4,4′-tetramethyl-1,1′-
diphospha-2-ferrocenyl)butanoic acid (2), its mono-
W(CO)5 complexes 3a and 3b, the bis-W(CO)5 complex
4, and corresponding active N-succinimidyl (NS) ester
5.
This ester is a potential metallocarbonyl diphospha-
ferrocenyl labeling reagent for biomolecules containing
amino groups. Its reactivity was tested toward model
compounds: benzylamine and glycine methyl ester.
Finally, we have determined the X-ray structures of 2
and 4. These structures shed new light on the hitherto
unclear conformational preference in the 1,1′-diphos-
phaferrocene system and on secondary bonds involving
phosphorus atoms.
Exp er im en ta l Section
Gen er a l Rem a r k s. All reactions were carried out under
an atmosphere of argon. Solvents were dried by using standard
procedures. Chromatographic purifications were carried out
on Silica gel 60 (230-400 mesh ASTM), purchased by Merck,
using chloroform as eluent. The NMR spectra were determined
1
on Varian Gemini 200 BB (200 MHz for H) in CDCl3 solutions.
They were calibrated by using internal Me4Si (1H and 13C) or
external 85% H3PO4 (31P) references. IR spectra were run on
a Specord 75 IR spectrometer. The combustion analyses were
determined by Analytical Services of the Center of Molecular
and Macromolecular Studies of the Polish Academy of the
Sciences (Ło´dz´). 3,4,3′,4′-Tetramethyl-1,1′-diphosphaferrocene
(1) was prepared according to the earlier published proce-
dure.14
4-Oxo-4-(3,3′,4,4′-tetr a m eth yl-1,1′-d ip h osp h a -2-fer r oce-
n yl)bu ta n oic Acid , 2. To a stirred and cooled to 0 °C
suspension of succinic anhydride (0.324 g, 3.24 mmol) in
dichloromethane (10 mL) was added AlCl3 (0.573 g, 4.32 mmol)
in one portion, and then a solution of DPF (0.600 g, 2.16 mmol)
in dichloromethane (5 mL) was slowly added (addition time
approximately 45 min). The resulting mixture was refluxed
for 3.5 h and hydrolyzed with a mixture of 2 M HCl (15 mL)
with ice. The organic layer was separated, and the water layer
was extracted with chloroform (3 × 15 mL). The combined
extracts were dried with sodium sulfate and evaporated to
dryness. Column chromatography (eluent chloroform) and
crystallization (dichloromethane-hexanes) afforded pure 2.
(6) (a) Osella, D.; Gambino, O.; Dutto, G. C.; Nervi, C.; J aouen,
Vessieres, A. Inorg. Chim. Acta 1994, 218, 207. (b) La Gal La Salle,
A.; Limoges, B.; Degrand, C.; Brossier, P. Anal. Chem.1995, 67, 1245.
(b) Limoges, B.; Degrand, C. Anal. Chem. 1996, 68, 4141.
(7) (a) Salmain, M.; Vessieres, A.; J aouen, G.; Butler, I. S. Anal.
Chem. 1991, 63, 2323. (b) Varenne, A.; Vessieres, A.; Brossier, P.;
J aouen, G. Res. Commun. Chem. Pathol. Pharmacol. 1994, 84, 81. (c)
Varenne, A.; Vessieres, A.; Salmain, M.; Brossier, P.; J aouen, G.
Immunoanal. Biol. Spectrosc. 1994, 9, 205. (d) Varenne, A.; Vessieres,
A.; Salmain, M.; Durand, S.; Brossier, P.; J aouen, G. Anal. Biochem.
1996, 242, 172.
(8) (a) Degani, Y.; Heller, A. J . Phys. Chem. 1987, 91, 1285. (b)
Degani, Y.; Heller, A. J . Am. Chem. Soc. 1988, 110, 2615. (c) Heller,
A. J . Chem. Phys. 1992, 96, 3579.
(9) (a) La Gal La Salle, A.; Limoges, B.; Degrand, C.; Brossier, P.
Anal. Chem. 1995, 67, 1245.
1
Yield: 0.650 g (80%). Mp: 146-148 °C (decomp). H NMR: δ
3.99 (d, J P-H ) 36.6 Hz, 1H, H-5); 3.73 and 3.69 (dd, J P-H
)
36.0 Hz, J H-H ) 2.0 Hz, 1H, 1H, H-2′ and H-5′); 2.99 (m, 2H,
CH2); 2.62 (m, 2H, CH2); 2.39, 2.10, 2.06, 1.98 (singlets, each
3H, Me’s).13 C NMR: δ 205.2 (d, J C-P ) 21.7 Hz, CO-ketone);
178.2 (s, CO-acid); 102.6 (d, J C-P ) 7.6 Hz), 99.27 (d, J C-P
)
7.3 Hz), 99.08 (d, J C-P ) 7.2 Hz) and 97.38 (d, J C-P ) 5.0 Hz);
C3,C3′, C4,′C4′, 84.1-82.4 (m, C2,C2′,C5,C5′); 37.32 (d, J C-P
) 12.3 Hz, CH2), 28.41 (br s CH2), 15.40, 14.58, 14.04, (s, Me’s).
31P NMR: δ -68.68 (td, J P-P ) 14.9 Hz, J P-H ) 36.0, P1′);
-53.15 (dd, J P-P ) 14.9 Hz, J P-H ) 36.6 Hz, P1). IR (CHCl3):
3300, 2080, 1995, 1720, 1670. Anal. Calcd for C16H20P2FeO3:
C, 50.82; H, 5.33. Found: C, 50.43; H, 5.41.
(10) Kraatz, H.-B.; Lusztyk, J .; Enright, G. D. Inorg. Chem. 1997,
36, 2400.
(11) For a recent survey see: Beer, D. Acc. Chem. Res. 1998, 31, 71.
(12) (a) Mathey, F. New J . Chem. 1987, 11, 585. (b) Mathey, F. J .
Organomet. Chem. 1990, 400, 149. (c) Dillon, K. B.; Mathey, F.; Nixon,
J . F. Phosphorus: The Carbon Copy; J . Wiley; Chichester, 1998. (d)
Ashe, A. J ., III; Kampf, J . W.; Pilotek, S.; Rousseau, R. Organometallics
1994, 13, 4067. (e) Ashe, A. J ., III; Al-Ahmad, S.; Pilotek, S.; Puranik,
D. B.; Elschenbroich, C.; Behrendt, A. Organometallics 1995, 14, 2689.
(f) Ashe, A. J ., III; Al-Ahmad, S. Adv. Organomet. Chem. 1996, 39,
325. (g) Kostic, N.; M.; Fenske, R. Organometallics 1983, 2, 1008. (h)
Guimon, C.; Gonbeau, D.; Pfister-Guillouzo, G.; de Lauzon, G.; Mathey,
F. Chem. Phys. Lett. 1984, 3, 1303. (i) Su, M.-D.; Chu, S.-Y. J . Phys.
Chem. 1989, 93, 6043.
Rea ction of 2 w ith W(CO)5(THF ). A solution of W(CO)5-
(THF) was prepared by irradiation through Pyrex (external
200 W high-pressure mercury lamp) of W(CO)6 (0.352 g, 1.0
mmol) in THF (150 mL) at room temperature for 1.5 h. In a
separate experiment this solution was treated with pyridine.
The amount of W(CO)5(py) isolated by column chromatography
indicated that 0.79 mmol of W(CO)5(THF) was generated
(assuming that reaction with pyridine proceeds quantitatively).
(13) Deschamps, B.; Mathey, F.; Fischer, J .; Nelson, J . H. Inorg.
Chem. 1984, 23, 3455.
(14) Mathey, F.; De Lauzon, G. Organometallic Synthesis; Elsevi-
er: Amsterdam, 1986; p 259.